慢性肾病对老年髋膝关节置换术后结局的影响:大型数据库研究
本研究基于美国国家手术质量改进计划数据库2006至2016年数据,回顾性分析193,747例65岁及以上行髋或膝关节置换术患者。结果显示,CKD 3b期和4期与髋置换术后30天主要并发症和死亡风险升高相关,与膝置换术后主要并发症风险升高相关,但与膝置换术后死亡无关。
要点
- CKD 3b和4期增加老年髋置换术后30天主要并发症和死亡风险。
- CKD 3b和4期增加老年膝置换术后30天主要并发症风险,但不增加死亡风险。
- 需进一步研究以指导围手术期管理决策。
核心结论
- 在老年患者中,CKD 3b期和4期与髋或膝关节置换术后30天主要并发症相关。
- CKD 3b期和4期与髋关节置换术后30天死亡相关,但与膝关节置换术后死亡无关。
研究设计与样本
- 回顾性研究,从美国国家手术质量改进计划数据库选取2006至2016年65岁及以上行髋或膝关节置换术的患者。
- 共纳入193,747例患者,其中68,424例(35.3%)行髋关节置换,125,323例(64.7%)行膝关节置换。
- 采用逻辑回归模型分析CKD分期与共同主要结局的关系。
主要发现
- 术后30天内,12,767例(6.6%)发生主要并发症,352例(0.2%)死亡。
临床怎么用
- 对老年髋或膝关节置换患者,应识别CKD 3b期和4期以评估术后30天主要并发症风险。
- 对合并CKD 3b期和4期的老年髋关节置换患者,需特别关注术后30天死亡风险。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hip and knee arthroplasties are among the most commonly performed surgical procedures in the elderly. In this age group, uncertainty exists regarding the importance of mild to moderate chronic kidney disease (CKD), which is prevalent but often unrecognized in the perioperative setting. This study evaluates the association between mild to moderate CKD and adverse postoperative outcomes in patients 65 years or older METHODS: This retrospective study selected patients 65 years or older undergoing hip or knee arthroplasty between 2006 and 2016 from the National Surgical Quality Improvement Program database. We created logistic regression models to analyze the relationship between CKD stage and each of our coprimary outcomes. The primary outcomes were major complication and mortality occurring within 30 days of surgery. RESULTS: Of the 193,747 included patients, 68,424 (35.3%) underwent hip and 125,323 (64.7%) knee arthroplasty. Within 30 days of surgery, 12,767 patients (6.6%) experienced a major complication and 352 (0.2%) died. Compared to patients with no kidney disease, patients with CKD stages 3b and 4 were at higher risk for both major complication (adjusted odds ratio [aOR] 1.28 [1.08-1.52], aOR 1.5 [1.13-1.98], respectively) and mortality (aOR 3.17 [1.23-8.14], aOR 3.93 [1.26-12.21], respectively) after hip arthroplasty, and for major complication (aOR 1.42 [1.23-1.63], aOR 1.52 [1.19-1.93], respectively) after knee arthroplasty. CONCLUSION: Among elderly patients, stage 3b and stage 4 CKD were associated with 30-day postoperative major complication after hip or knee arthroplasty, and with 30-day postoperative mortality after hip, but not knee, arthroplasty. Further research will be required to inform perioperative management decisions.
引用
- Antoniak DT, Benes BJ, Hartman CW, et al. Impact of Chronic Kidney Disease in Older Adults Undergoing Hip or Knee Arthroplasty: A Large Database Study. J Arthroplasty. 2019. PMID: 31948811. doi:10.1016/j.arth.2019.12.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。